IMMUNOCAN

Immunocan was founded in 2020 and specializes in using gene editing technology to replace immunoglobulin variable region...

Laboratory

• Contact: -
• Phone: -
• E-mail: -
• Address: No.398 Xinlai Road, Jiading District Shanghai, 201815 China
• State: Shanghai
• Company Website: -
• Company Category: -
• Number of Employees: -
• Tax ID: -
• Annual Revenue: -
• Last Updated: 03/23/2026
• About the Company:
  Immunocan was founded in 2020 and specializes in using gene editing technology to replace immunoglobulin variable region genes in various animals, resulting in genetically engineered animals capable of producing fully human antibodies and other innovative modalities. The company is committed to offering cutting-edge antibody discovery platforms to worldwide drug research partners, with the goal of developing safer and more effective treatments for human diseases.
• Products:
  Biology